Vaccine Immunology Clinical Studies
Vaccine Clinical Research in Columbus
Clinical research serves a vital role in the development of novel (new) vaccine candidates. Because vaccines are given to millions of healthy people to prevent serious diseases, they’re held to very high safety standards. A new vaccine must be evaluated for safety, immunogenicity, and protective efficacy in humans before it is licensed for use by the Food and Drug Administration (FDA) and recommended for use by the Centers for Disease Control and Prevention (CDC).
Vaccine Trials We Offer
At Aventiv, we offer a number of vaccine candidate trials. During a clinical trial, an investigational vaccine is tested on healthy people who volunteer to get vaccinated. A healthy volunteer is someone with no known significant health problems who participates in research to test a new drug, device, or intervention. Your participation in a clinical trial could lead to a new treatment that helps someone you care about. Please refer to each study’s page for detailed participant information.
Chikungunya Vaccine Study
Aventiv Research is currently participating in a Chikungunya vaccine study at our Columbus, Ohio location.
COVID-19 Antibody Treatment Study
Aventiv Research is currently participating in a COVID-19 monoclonal antibody (mAb) treatment study at our Columbus, Ohio location.
Pneumococcal Vaccine Study
Aventiv Research is currently participating in a pneumococcal vaccine study at our Columbus, Ohio location.